AETHLON MEDICAL INC (AEMD) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US00808Y6041
AETHLON MEDICAL INC financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Operating income | -9.34 m USD | -7.29 m USD |
| EBIT | -13.38 m USD | -7.29 m USD |
| Net income | -13.39 m USD | -7.15 m USD |
| Diluted EPS – continuing operations | -8.58 USD | -10.61 USD |
Full history since 2010, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About AETHLON MEDICAL INC
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states. The company was founded in 1984 and is based in San Diego, California.
More stocks
- BEASLEY BROADCAST GROUP INC (BBGI)
- CHICAGO RIVET & MACHINE CO (CVR)
- ASTROTECH Corp (ASTC)
- XERIANT, INC. (XERI)
- Glucose Health, Inc. (GLUC)
- CISO Global, Inc. (CISO)
- VPR Brands, LP. (VPRB)
- Summit Networks Inc. (SNTW)
- SUPA Consolidated Inc. (SFCX)
- PURE BIOSCIENCE, INC. (PURE)
- Worldwide NFT Inc. (WNFT)
- Crown Equity Holdings, Inc. (CRWE)
Not investment advice. All data without warranty, price as of 17.11.2026. Details in the risk notice.